Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kane Biotech Inc KNBIF


Primary Symbol: V.KNE

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired... see more

Recent & Breaking News (TSXV:KNE)

Kane Biotech to Release Second Quarter 2022 Financial Results on August 25, 2022 - Conference Call to Follow

GlobeNewswire August 18, 2022

Kane Biotech Announces Adoption of Amended and Restated Stock Option Plan and Performance and Restricted Share Unit Plan

GlobeNewswire June 30, 2022

Kane Biotech Announces Amended Credit Facility

GlobeNewswire June 15, 2022

Kane Biotech Announces First Quarter 2022 Financial Results

GlobeNewswire May 26, 2022

Kane Biotech to Release First Quarter 2022 Financial Results on May 26 - Conference Call to Follow

GlobeNewswire May 19, 2022

Kane Biotech Inc. (TSXV:KNE) obtains ISO 13485 certification

Shoran Devi May 18, 2022

Kane Biotech Obtains ISO 13485 Certification

GlobeNewswire May 18, 2022

Kane Biotech (TSXV:KNE) closes private placement

John Ballem  May 17, 2022

Kane Biotech Announces Closing of Private Placement

GlobeNewswire May 17, 2022

Kane Biotech (TSXV:KNE) to close fully subscribed private placement

Trevor Abes  May 6, 2022

Kane Biotech Announces Update on Private Placement

GlobeNewswire May 6, 2022

Kane Biotech Announces Extension of Private Placement Offering

GlobeNewswire April 29, 2022

Kane Biotech's (TSXV:KNE) joint venture receives certification, triggering $1.3M in milestone payments

Caroline Egan  April 7, 2022

IIROC Trading Resumption - KNE

Canada NewsWire April 7, 2022

STEM Animal Health Awarded Veterinary Oral Health Council (VOHC) Seal of Acceptance for Pet Oral Care Water Additive

GlobeNewswire April 7, 2022

IIROC Trading Halt - KNE

Canada NewsWire April 7, 2022

Kane Biotech Appoints Dr. Gregory Schultz as Chief Scientific Officer

GlobeNewswire April 5, 2022

Kane Biotech Announces Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire March 24, 2022

Kane Biotech (TSXV:KNE) completes safety studies for DispersinB

Caroline Egan  March 22, 2022

Kane Biotech Successfully Completes Safety and Biocompatibility Studies for DispersinB® Wound Gel in Preparation for Human Clinical Trials

GlobeNewswire March 22, 2022